226 related articles for article (PubMed ID: 10495437)
1. Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides.
Miao HQ; Elkin M; Aingorn E; Ishai-Michaeli R; Stein CA; Vlodavsky I
Int J Cancer; 1999 Oct; 83(3):424-31. PubMed ID: 10495437
[TBL] [Abstract][Full Text] [Related]
2. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of tumor metastasis by heparanase inhibiting species of heparin.
Vlodavsky I; Mohsen M; Lider O; Svahn CM; Ekre HP; Vigoda M; Ishai-Michaeli R; Peretz T
Invasion Metastasis; 1994-1995; 14(1-6):290-302. PubMed ID: 7657522
[TBL] [Abstract][Full Text] [Related]
4. Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties.
Lapierre F; Holme K; Lam L; Tressler RJ; Storm N; Wee J; Stack RJ; Castellot J; Tyrrell DJ
Glycobiology; 1996 Apr; 6(3):355-66. PubMed ID: 8724143
[TBL] [Abstract][Full Text] [Related]
5. Chemically modified heparins as inhibitors of heparan sulfate specific endo-beta-glucuronidase (heparanase) of metastatic melanoma cells.
Irimura T; Nakajima M; Nicolson GL
Biochemistry; 1986 Sep; 25(18):5322-8. PubMed ID: 3768351
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of tumor invasion and metastasis by calcium spirulan (Ca-SP), a novel sulfated polysaccharide derived from a blue-green alga, Spirulina platensis.
Mishima T; Murata J; Toyoshima M; Fujii H; Nakajima M; Hayashi T; Kato T; Saiki I
Clin Exp Metastasis; 1998 Aug; 16(6):541-50. PubMed ID: 9872601
[TBL] [Abstract][Full Text] [Related]
7. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells.
Savion N; Disatnik MH; Nevo Z
J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131
[TBL] [Abstract][Full Text] [Related]
8. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
[TBL] [Abstract][Full Text] [Related]
9. Evidence that sulphated polysaccharides inhibit tumour metastasis by blocking tumour-cell-derived heparanases.
Parish CR; Coombe DR; Jakobsen KB; Bennett FA; Underwood PA
Int J Cancer; 1987 Oct; 40(4):511-8. PubMed ID: 3666989
[TBL] [Abstract][Full Text] [Related]
10. P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins.
Hostettler N; Naggi A; Torri G; Ishai-Michaeli R; Casu B; Vlodavsky I; Borsig L
FASEB J; 2007 Nov; 21(13):3562-72. PubMed ID: 17557930
[TBL] [Abstract][Full Text] [Related]
11. Cancer cell heparanase activity associated with invasion and metastasis.
Nicolson GL; Nakajima M; Wakabayashi H; Boyd DD; Diaz D; Irimura T
Adv Enzyme Regul; 1998; 38():19-32. PubMed ID: 9762344
[No Abstract] [Full Text] [Related]
12. Suramin. A potent inhibitor of melanoma heparanase and invasion.
Nakajima M; DeChavigny A; Johnson CE; Hamada J; Stein CA; Nicolson GL
J Biol Chem; 1991 May; 266(15):9661-6. PubMed ID: 2033058
[TBL] [Abstract][Full Text] [Related]
13. Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity.
Parish CR; Freeman C; Brown KJ; Francis DJ; Cowden WB
Cancer Res; 1999 Jul; 59(14):3433-41. PubMed ID: 10416607
[TBL] [Abstract][Full Text] [Related]
14. Sulfated hexasaccharides attenuate metastasis by inhibition of P-selectin and heparanase.
Borsig L; Vlodavsky I; Ishai-Michaeli R; Torri G; Vismara E
Neoplasia; 2011 May; 13(5):445-52. PubMed ID: 21532885
[TBL] [Abstract][Full Text] [Related]
15. O-sulfated bacterial polysaccharides with low anticoagulant activity inhibit metastasis.
Borgenström M; Wärri A; Hiilesvuo K; Käkönen R; Käkönen S; Nissinen L; Pihlavisto M; Marjamäki A; Vlodavsky I; Naggi A; Torri G; Casu B; Veromaa T; Salmivirta M; Elenius K
Semin Thromb Hemost; 2007 Jul; 33(5):547-56. PubMed ID: 17629853
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of polysulfated polysaccharide on experimental encephalomyelitis, proliferation of autoimmune T cells, and inhibition of heparanase activity.
Hershkoviz R; Mor F; Miao HQ; Vlodavsky I; Lider O
J Autoimmun; 1995 Oct; 8(5):741-50. PubMed ID: 8579728
[TBL] [Abstract][Full Text] [Related]
17. Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activity.
Miao HQ; Ishai-Michaeli R; Peretz T; Vlodavsky I
J Cell Physiol; 1995 Sep; 164(3):482-90. PubMed ID: 7650058
[TBL] [Abstract][Full Text] [Related]
18. Alternatively spliced Spalax heparanase inhibits extracellular matrix degradation, tumor growth, and metastasis.
Nasser NJ; Avivi A; Shafat I; Edovitsky E; Zcharia E; Ilan N; Vlodavsky I; Nevo E
Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2253-8. PubMed ID: 19164514
[TBL] [Abstract][Full Text] [Related]
19. Heparanase expression in B16 melanoma cells and peripheral blood neutrophils before and after extravasation detected by novel anti-mouse heparanase monoclonal antibodies.
Komatsu N; Waki M; Sue M; Tokuda C; Kasaoka T; Nakajima M; Higashi N; Irimura T
J Immunol Methods; 2008 Feb; 331(1-2):82-93. PubMed ID: 18162185
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of heparanase activity and heparanase-induced angiogenesis by suramin analogues.
Marchetti D; Reiland J; Erwin B; Roy M
Int J Cancer; 2003 Mar; 104(2):167-74. PubMed ID: 12569571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
